Companion Animal Health Market, By Animal Type (Equine, Dogs, Sheep & Goats, Cats, and Poultry), By Product (Vaccines, Pharmaceuticals, Feed Additives, Diagnostics, and Others), By Drug, By Distribution Channel, By Application and Geography (NA, EU, APAC, and RoW) Analysis, Share, Trends, Size, & Forecast From 2014 2025
REPORT HIGHLIGHT
The companion animal health market is estimated to represent a global market of USD 12,506 million by 2017 with growth rate of 4.8%.
Market Dynamics
Companion animal health industry includes all products and services (i.e. pet services, diagnostics and OTC health) for dogs, horses, cats, and others. The growth of this industry is majorly influenced by the strong increase in the rate of pet ownership. Further, rising strategic collaborations of companies with veterinary organizations to promote awareness and improve animal health augment the market growth significantly. For instance, in 2015, Ceva partnered with the America Association of Feline Practitioners, aimed to encourage pet owner to standardize animal research and surgery practices.
Over the past few years, research and development activities in the veterinary industry have increased and thus the spending on companion animal health. According to American Pet Product Association (APPA), companion animal spending has been consistently on the rise. The organization stated that in 2011, the spending on pet industry was around USD 51 billion and is expected to reach USD 69.36 billion by 2017. The statistics from APPA also stated that around 20.0% of this spending was found to be on over-the-counter products and food & supplies, whereas 25.0% was on veterinary care, including pharmaceuticals.
In May 2015, the Federal Trade Commission (FTC) also stated that the market for veterinary medicine has shown significant growth in recent years. The organization estimated that prescription and over the counter medicine for the dogs and cats are projected to increase with a significant growth rate over the future period. All such facts indicate the rise in adoption of companion animal therapeutics thus, augment the market growth.
Furthermore, the emergence of veterinary information systems and implementation of it into fields such as consultant systems for diagnostic assistance, drug information systems, diagnostic decision assistance, and teaching tools has further aided in the growth of the market. On the flip side, increasing influx of sub-standard therapeutics in veterinary industry is considered to be the major growth restricting factors. Additionally, an absence of streamlining of national regulatory processes will hamper the industry growth to some extent.
Animal Type Takeaway
Animal type segment is categorized as Equine, Dogs, Sheep & Goats, Cats, and Poultry. Among which, dogs accounted for the largest share of the total market, has recorded USD 4.83 billion in 2016. The demand for dog’s therapeutics is relatively greater than other companion animals and the trend is likely to continue over the future period. Thus, companies are increasingly developing novel therapeutics under this segment. For instance, in May 2016, European Medicines Agency (EMA) approved Merck’s Bravecto Spot-on solution to treat flea and ticks in dogs. Later, in July 2016, the company also received U.S. FDA approval for this product under name Bravecto Topical.
Product Takeaway
Product segment is divided into Vaccines, Pharmaceuticals, Feed Additives, Diagnostics, and Others. Increasing research and development activities coupled with favorable government initiatives has helped pharmaceuticals segment to be on the top spot. Drugs segment is categorized into Over the Counter (OTC) and Prescription. Whereas, distribution channel segment is bifurcated into E-commerce, Retail, and Hospitals. The application segment is divided in terms of Clinics, Point-of-Care Facilities, and others.
Regional Takeaway
Regionally, North America accounted for the largest share, closely followed by Europe. Presence of a large number of established pharmaceutical companies that are consistently striving for extensive commercialization of their veterinary products is presumed to be a key factor responsible for growth in both regions. Asia Pacific region is projected to grow with the highest CAGR owing to the rise in adoption of companion animals coupled with the increasing disposable income.
Key Vendor Takeaway
Companies namely Merck, Nutreco, Zoetis, Boehringer Ingelheim, Bayer AG, and Virbac are profiled in detail. Among which, the most notable market participants are Nutreco, Bayer, and Zoetis, accounting for the majority of the revenue share. Key players operating in this market are majorly involved in the development of new products and strategic expansion of their geographic reach. For example, Zoetis offers products such as Cerenia, Convenia, Synulox, Dexdomitor, Cerenia, Palladia, and Rimadyl under companion animal therapeutics. Recently, in December 2016, US FDA approved company’s first monoclonal antibody product named “CYTOPOINT”. This drug act by neutralizing interleukin-31 (IL-31) and provide long-lasting relief from atopic dermatitis in dogs.
The market size and forecast for each segment and sub-segments has been considered as below:
- Historical Year – 2014 & 2016
- Base Year – 2017
- Estimated Year – 2018
- Projected Year – 2025
TARGET AUDIENCE
- Traders, Distributors, and Suppliers
- Manufacturers
- Hospitals
- Government and Regional Agencies and Research Organizations
- Consultants
- Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
MARKET, BY ANIMAL TYPE
- Equine
- Dogs
- Sheep & Goats
- Cats
- Poultry
MARKET, BY PRODUCT
- Vaccines
- Pharmaceuticals
- Feed Additives
- Diagnostics
- Others
MARKET, BY DRUG
- OTC
- Prescription
MARKET, BY DISTRIBUTION CHANNEL
- E-commerce
- Retail
- Hospitals
MARKET, BY APPLICATION
- Clinics
- Point-of-Care Facilities
- Others
MARKET, BY REGION
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- Rest of Europe
- Asia Pacific
- India
- China
- Rest of APAC
- Rest of the World
- Middle East and Africa
- Latin America
TABLE OF CONTENT
1. COMPANION ANIMAL HEALTH MARKET OVERVIEW
1.1. Study Scope
1.2. Base Year
1.3. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Key Market Facts
2.2. Geographical Scenario
2.3. Companies in the Market
3. COMPANION ANIMAL HEALTH KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. COMPANION ANIMAL HEALTH INDUSTRY STUDY
4.1. Porter’s Analysis
4.2. Market Attractiveness Analysis
4.3. Regulatory Framework Analysis
5. COMPANION ANIMAL HEALTH MARKET LANDSCAPE
5.1. Market Share Analysis
6. COMPANION ANIMAL HEALTH MARKET – BY ANIMAL TYPE:
6.1. Overview
6.2. Equine
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.3. Dogs
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.4. Sheep & Goats
6.4.1. Overview
6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.5. Cats
6.5.1. Overview
6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.6. Poultry
6.6.1. Overview
6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7. COMPANION ANIMAL HEALTH MARKET – BY PRODUCT:
7.1. Overview
7.2. Vaccines
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.3. Pharmaceuticals
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.4. Feed Additives
7.4.1. Overview
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.5. Diagnostics
7.5.1. Overview
7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.6. Others
7.6.1. Overview
7.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8. COMPANION ANIMAL HEALTH MARKET – BY DRUG:
8.1. Overview
8.2. OTC
8.2.1. Overview
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.3. Prescription
8.3.1. Overview
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9. COMPANION ANIMAL HEALTH MARKET – BY DISTRIBUTION CHANNEL:
9.1. Overview
9.2. E-commerce
9.2.1. Overview
9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.3. Retail
9.3.1. Overview
9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.4. Hospitals
9.4.1. Overview
9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
10. COMPANION ANIMAL HEALTH MARKET – BY APPLICATION:
10.1. Overview
10.2. Clinics
10.2.1. Overview
10.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
10.3. Point-of-Care Facilities
10.3.1. Overview
10.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
10.4. Others
10.4.1. Overview
10.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
11. COMPANION ANIMAL HEALTH MARKET– BY GEOGRAPHY
11.1. Introduction
11.2. North America
11.2.1. Overview
11.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
11.2.3. U.S.
11.2.3.1. Overview
11.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
11.2.4. Canada
11.2.4.1. Overview
11.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
11.3.3. France
11.3.3.1. Overview
11.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
11.3.4. Germany
11.3.4.1. Overview
11.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
11.3.5. Rest of Europe
11.3.5.1. Overview
11.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
11.4.3. China
11.4.3.1. Overview
11.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
11.4.4. India
11.4.4.1. Overview
11.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
11.4.5. Rest of APAC
11.4.5.1. Overview
11.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
11.5. Rest of the World
11.5.1. Overview
11.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
11.5.3. Latin America
11.5.3.1. Overview
11.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
11.5.4. Middle East and Africa
11.5.4.1. Overview
11.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
12. KEY VENDOR ANALYSIS
12.1. Merck
12.1.1. Company Overview
12.1.2. SWOT Analysis
12.1.3. Key Developments
12.2. Nutreco
12.2.1. Company Overview
12.2.2. SWOT Analysis
12.2.3. Key Developments
12.3. Zoetis
12.3.1. Company Overview
12.3.2. SWOT Analysis
12.3.3. Key Developments
12.4. Boehringer Ingelheim
12.4.1. Company Overview
12.4.2. SWOT Analysis
12.4.3. Key Developments
12.5. Bayer AG
12.5.1. Company Overview
12.5.2. SWOT Analysis
12.5.3. Key Developments
12.6. Virbac
12.6.1. Company Overview
12.6.2. SWOT Analysis
12.6.3. Key Developments
*Client can request additional company profiling as per specific requirements
13. 360 DEGREE ANALYSTVIEW
14. APPENDIX
14.1. Research Methodology
14.2. Abbreviations
14.3. Disclaimer
14.4. Contact Us
List of Tables
Table 1 List of Acronyms
Table 2 Key Market Facts, 2014 – 2025
Table 3 Market Drivers: Impact Analysis
Table 4 Market Restraint: Impact Analysis
Table 5 Market Opportunity: Impact Analysis
Table 6 PEST Analysis
Table 7 Porter’s Five Forces Analysis
Table 8 Company Market Share Analysis
Table 9 Global Companion Animal Health Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
Table 10 Companion Animal Health Market, by Animal Type, 2014 – 2025 (USD Million)
Table 11 Companion Animal Health Market, by Product, 2014 – 2025 (USD Million)
Table 12 Companion Animal Health Market, by Drug, 2014 – 2025 (USD Million)
Table 13 Companion Animal Health Market, by Distribution Channel, 2014 – 2025 (USD Million)
Table 14 Companion Animal Health Market, by Application, 2014 – 2025 (USD Million)
Table 15 Companion Animal Health Market, by Geography, 2014 – 2025 (USD Million)
Table 16 North America Companion Animal Health Market, 2014 – 2025 (USD Million)
Table 17 U.S. Companion Animal Health Market, 2014 – 2025 (USD Million)
Table 18 Canada Companion Animal Health Market, 2014 – 2025 (USD Million)
Table 19 Europe Companion Animal Health Market, 2014 – 2025 (USD Million)
Table 20 France Companion Animal Health Market, 2014 – 2025 (USD Million)
Table 21 Germany Companion Animal Health Market, 2014 – 2025 (USD Million)
Table 22 Asia Pacific Companion Animal Health Market, 2014 – 2025 (USD Million)
Table 23 China Companion Animal Health Market, 2014 – 2025 (USD Million)
Table 24 India Companion Animal Health Market, 2014 – 2025 (USD Million)
Table 25 Latin America Companion Animal Health Market, 2014 – 2025 (USD Million)
Table 26 MEA Companion Animal Health Market, 2014 – 2025 (USD Million)
List of Figures
Figure 1 Research Methodology
Figure 2 Research Process Flow Chart
Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)
Figure 4 Regulatory Framework Analysis
Figure 5 Value Chain Analysis Analysis
Figure 6 Companion Animal Health Market, by Animal Type, 2014 – 2025 (USD Million)
Figure 7 Companion Animal Health Market, by Product, 2014 – 2025 (USD Million)
Figure 8 Companion Animal Health Market, by Drug, 2014 – 2025 (USD Million)
Figure 8 Companion Animal Health Market, by Distribution Channel, 2014 – 2025 (USD Million)
Figure 8 Companion Animal Health Market, by Application, 2014 – 2025 (USD Million)
Figure 9 Companion Animal Health Market, by Geography, 2014 – 2025 (USD Million)
